Imagin Medical Inc. (IMEXF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2022 | 1.35 Million CAD | 74.41% |
| 2021 | 774.51 Thousand CAD | 253.02% |
| 2020 | 219.4 Thousand CAD | -91.2% |
| 2019 | 2.49 Million CAD | -59.58% |
| 2018 | 6.17 Million CAD | 1483.93% |
| 2017 | 389.64 Thousand CAD | 10.96% |
| 2016 | 351.16 Thousand CAD | 746.21% |
| 2015 | 41.49 Thousand CAD | -86.21% |
| 2014 | 300.93 Thousand CAD | -86.84% |
| 2013 | 2.28 Million CAD | -15.99% |
| 2012 | 2.72 Million CAD | -43.39% |
| 2011 | 4.8 Million CAD | 58.8% |
| 2010 | 3.02 Million CAD | -16.51% |
| 2009 | 3.62 Million CAD | -57.52% |
| 2008 | 8.53 Million CAD | -41.57% |
| 2007 | 14.6 Million CAD | 51.28% |
| 2006 | 9.65 Million CAD | 306.22% |
| 2005 | 2.37 Million CAD | 431.97% |
| 2004 | 446.9 Thousand CAD | -13.08% |
| 2003 | 514.16 Thousand CAD | -46.77% |
| 2002 | 965.85 Thousand CAD | 16.19% |
| 2001 | 831.27 Thousand CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q3 | 1.11 Million CAD | -2.24% |
| 2023 Q1 | 1.19 Million CAD | -11.24% |
| 2023 Q2 | 1.14 Million CAD | -4.73% |
| 2022 Q1 | 570.52 Thousand CAD | -26.34% |
| 2022 FY | 1.35 Million CAD | 74.41% |
| 2022 Q2 | 1.34 Million CAD | 135.09% |
| 2022 Q4 | 1.35 Million CAD | 193.06% |
| 2022 Q3 | 460.94 Thousand CAD | -65.63% |
| 2021 Q1 | 585.89 Thousand CAD | 167.04% |
| 2021 Q2 | 1.56 Million CAD | 166.98% |
| 2021 Q4 | 774.51 Thousand CAD | -39.08% |
| 2021 Q3 | 1.27 Million CAD | -18.72% |
| 2021 FY | 774.51 Thousand CAD | 253.02% |
| 2020 Q1 | 1.24 Million CAD | -50.14% |
| 2020 Q3 | 510.69 Thousand CAD | -58.23% |
| 2020 Q4 | 219.4 Thousand CAD | -57.04% |
| 2020 FY | 219.4 Thousand CAD | -91.2% |
| 2020 Q2 | 1.22 Million CAD | -1.7% |
| 2019 Q2 | 4.77 Million CAD | -16.2% |
| 2019 FY | 2.49 Million CAD | -59.58% |
| 2019 Q1 | 5.69 Million CAD | -7.74% |
| 2019 Q3 | 3.68 Million CAD | -22.77% |
| 2019 Q4 | 2.49 Million CAD | -32.31% |
| 2018 Q2 | 3.93 Million CAD | 97.11% |
| 2018 Q4 | 6.17 Million CAD | -11.7% |
| 2018 FY | 6.17 Million CAD | 1483.93% |
| 2018 Q1 | 1.99 Million CAD | 411.71% |
| 2018 Q3 | 6.98 Million CAD | 77.83% |
| 2017 Q3 | 240.11 Thousand CAD | -19.22% |
| 2017 FY | 389.64 Thousand CAD | 10.96% |
| 2017 Q1 | 436.94 Thousand CAD | 24.43% |
| 2017 Q2 | 297.25 Thousand CAD | -31.97% |
| 2017 Q4 | 389.64 Thousand CAD | 62.27% |
| 2016 Q3 | 528.39 Thousand CAD | -44.29% |
| 2016 FY | 351.16 Thousand CAD | 746.21% |
| 2016 Q4 | 351.16 Thousand CAD | -33.54% |
| 2016 Q2 | 948.48 Thousand CAD | 353.56% |
| 2016 Q1 | 209.11 Thousand CAD | 403.93% |
| 2015 FY | 41.49 Thousand CAD | -86.21% |
| 2015 Q4 | 41.49 Thousand CAD | -48.8% |
| 2015 Q3 | 81.05 Thousand CAD | -47.99% |
| 2015 Q2 | 155.83 Thousand CAD | -36.27% |
| 2015 Q1 | 244.5 Thousand CAD | -18.75% |
| 2014 Q3 | 1.65 Million CAD | -22.3% |
| 2014 FY | 300.93 Thousand CAD | -86.84% |
| 2014 Q4 | 300.93 Thousand CAD | -81.87% |
| 2014 Q1 | 2.18 Million CAD | -4.42% |
| 2014 Q2 | 2.13 Million CAD | -2.27% |
| 2013 Q3 | 2.31 Million CAD | -5.88% |
| 2013 Q2 | 2.45 Million CAD | -5.82% |
| 2013 Q4 | 2.28 Million CAD | -1.05% |
| 2013 FY | 2.28 Million CAD | -15.99% |
| 2013 Q1 | 2.6 Million CAD | -4.23% |
| 2012 Q1 | 4.27 Million CAD | -11.03% |
| 2012 Q3 | 4.21 Million CAD | 1.71% |
| 2012 Q4 | 2.72 Million CAD | -35.46% |
| 2012 FY | 2.72 Million CAD | -43.39% |
| 2012 Q2 | 4.14 Million CAD | -3.06% |
| 2011 Q2 | 5.33 Million CAD | 39.94% |
| 2011 Q3 | 4.71 Million CAD | -11.66% |
| 2011 Q4 | 4.8 Million CAD | 1.98% |
| 2011 FY | 4.8 Million CAD | 58.8% |
| 2011 Q1 | 3.81 Million CAD | 25.96% |
| 2010 Q1 | 3.08 Million CAD | -14.99% |
| 2010 FY | 3.02 Million CAD | -16.51% |
| 2010 Q4 | 3.02 Million CAD | 20.79% |
| 2010 Q3 | 2.5 Million CAD | -17.17% |
| 2010 Q2 | 3.02 Million CAD | -1.84% |
| 2009 FY | 3.62 Million CAD | -57.52% |
| 2009 Q4 | 3.62 Million CAD | -55.77% |
| 2009 Q3 | 8.19 Million CAD | 5.24% |
| 2009 Q2 | 7.79 Million CAD | -1.38% |
| 2009 Q1 | 7.89 Million CAD | -7.47% |
| 2008 Q2 | 14.97 Million CAD | -9.36% |
| 2008 Q4 | 8.53 Million CAD | -30.69% |
| 2008 Q3 | 12.31 Million CAD | -17.73% |
| 2008 FY | 8.53 Million CAD | -41.57% |
| 2008 Q1 | 16.51 Million CAD | 13.05% |
| 2007 Q3 | 13.11 Million CAD | 8.74% |
| 2007 Q4 | 14.6 Million CAD | 11.39% |
| 2007 Q2 | 12.06 Million CAD | 2.61% |
| 2007 Q1 | 11.75 Million CAD | 21.72% |
| 2007 FY | 14.6 Million CAD | 51.28% |
| 2006 Q2 | 7.71 Million CAD | 141.17% |
| 2006 Q1 | 3.19 Million CAD | 34.52% |
| 2006 FY | 9.65 Million CAD | 306.22% |
| 2006 Q4 | 9.65 Million CAD | -1.14% |
| 2006 Q3 | 9.76 Million CAD | 26.65% |
| 2005 Q1 | 401.28 Thousand CAD | -10.21% |
| 2005 FY | 2.37 Million CAD | 431.97% |
| 2005 Q2 | 828.09 Thousand CAD | 106.36% |
| 2005 Q4 | 2.37 Million CAD | -1.49% |
| 2005 Q3 | 2.41 Million CAD | 191.44% |
| 2004 Q2 | 496.33 Thousand CAD | -2.34% |
| 2004 Q3 | 475.82 Thousand CAD | -4.13% |
| 2004 Q1 | 508.21 Thousand CAD | -1.16% |
| 2004 Q4 | 446.9 Thousand CAD | -6.08% |
| 2004 FY | 446.9 Thousand CAD | -13.08% |
| 2003 FY | 514.16 Thousand CAD | -46.77% |
| 2003 Q1 | 952.05 Thousand CAD | -1.43% |
| 2003 Q3 | 908.82 Thousand CAD | -2.25% |
| 2003 Q2 | 929.71 Thousand CAD | -2.35% |
| 2003 Q4 | 514.16 Thousand CAD | -43.43% |
| 2002 Q1 | 780.8 Thousand CAD | 0.0% |
| 2002 Q2 | 1.02 Million CAD | 31.62% |
| 2002 FY | 965.85 Thousand CAD | 16.19% |
| 2002 Q4 | 965.85 Thousand CAD | 1.1% |
| 2002 Q3 | 955.35 Thousand CAD | -7.04% |
| 2001 FY | 831.27 Thousand CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Manhattan Scientifics, Inc. | 316 Thousand USD | -327.48% |
| Össur hf. | 1.39 Billion USD | 99.903% |
| QHSLab, Inc. | 1.68 Million USD | 19.662% |
| Wellstar International, Inc. | 957.89 Thousand USD | -41.022% |
| Össur hf. | 1.39 Billion USD | 99.903% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 4.75 Million USD | 71.609% |
| Aurora Spine Corporation | 11.92 Million USD | 88.671% |
| BrainsWay Ltd. | 62.97 Million USD | 97.855% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| AVITA Medical, Inc. | 144.33 Million USD | 99.064% |
| CVR Medical Corp. | - USD | -Infinity% |
| Hamilton Thorne Ltd. | 110.16 Million USD | 98.774% |
| BioElectronics Corporation | 144.38 Thousand USD | -835.56% |
| Vivos Inc. | 1.61 Million USD | 16.104% |
| Kelyniam Global, Inc. | 1.63 Million USD | 17.263% |
| Zecotek Photonics Inc. | 2.57 Million USD | 47.497% |
| REMSleep Holdings, Inc. | 1.2 Million USD | -11.981% |
| EKF Diagnostics Holdings plc | 102.92 Million USD | 98.687% |
| Avitar, Inc. | 1.74 Million USD | 22.713% |
| Nanomix Corporation | 982.05 Thousand USD | -37.552% |
| Theraclion SA | 18.66 Million EUR | 92.762% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 182.18 Thousand USD | -641.485% |
| NewCardio, Inc. | 2.85 Million USD | 52.653% |
| Positron Corporation | 1.76 Million USD | 23.58% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 748.38 Thousand USD | -80.501% |
| Lombard Medical, Inc. | 67.76 Million USD | 98.007% |
| ALR Technologies Inc. | 193.21 Thousand USD | -599.129% |
| Stratec SE | 529.71 Million USD | 99.745% |
| Vycor Medical, Inc. | 992.29 Thousand USD | -36.132% |
| Heart Tronics, Inc. | 4.04 Million USD | 66.637% |
| Nu-Med Plus, Inc. | 2.21 Million USD | 38.932% |
| MicroPort Scientific Corporation | 3.93 Billion USD | 99.966% |
| VMS Rehab Systems, Inc. | 4.45 USD | -30355787.64% |
| Guided Therapeutics, Inc. | 1.66 Million USD | 19.063% |
| Ingen Technologies, Inc. | 737.73 Thousand USD | -83.105% |
| CYduct Diagnostics, Inc. | 54.74 Thousand USD | -2367.372% |
| Odyssey Group International, Inc. | 455.79 Thousand USD | -196.371% |
| SANUWAVE Health, Inc. | 22.41 Million USD | 93.974% |
| IR-Med Inc. | 999 Thousand USD | -35.219% |
| Perimeter Medical Imaging AI, Inc. | 20.54 Million USD | 93.424% |
| United American Healthcare Corporation | 10.37 Million USD | 86.985% |
| Polarean Imaging plc | 10.86 Million USD | 87.57% |
| ECGI Holdings, Inc. | 5.2 Million USD | 74.029% |
| Capital Group Holdings, Inc. | 33.79 Thousand USD | -3897.269% |
| ADM Tronics Unlimited, Inc. | 2.13 Million USD | 36.839% |
| Medical Supply International USA, Inc. | 870.77 Thousand USD | -55.131% |
| Rapid Therapeutic Science Laboratories, Inc. | 2.25 Million USD | 40.085% |
| Nexeon MedSystems Inc. | 20.35 Million USD | 93.362% |
| SS Innovations International, Inc. | 25.47 Million USD | 94.698% |
| Urologix, Inc. | 5.66 Million USD | 76.163% |
| Qualis Innovations, Inc. | 2431.00 USD | -55467.133% |
| Smith & Nephew plc | 9.97 Billion USD | 99.986% |
| NIOX Group Plc | 116.47 Million USD | 98.84% |
| Fuse Medical, Inc. | 16.25 Million USD | 91.692% |
| Broncus Holding Corporation | 195.75 Million USD | 99.31% |
| Brain Scientific Inc. | 11.74 Million USD | 88.497% |
| Pressure BioSciences, Inc. | 1.04 Million USD | -28.691% |
| Health Logic Interactive Inc. | 28.73 Thousand USD | -4601.016% |